Viridian Therapeutics, Inc. (VRDN)

27.58 -0.52 (-1.85%) USD  |  NASDAQ  |  Feb 20, 15:42
More

Viridian Therapeutics Price Target Std Dev

Price Target Std Dev Chart

View Price Target Std Dev for VRDN.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Price Target Std Dev Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Price Target Std Dev Range, Past 5 Years

View Price Target Std Dev Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Price Target Std Dev Benchmarks

View Price Target Std Dev Benchmarks
Start Trial
Marker Therapeutics, Inc. Upgrade
ADMA Biologics, Inc. Upgrade
Avantor, Inc. Upgrade
Immunovant, Inc. Upgrade
Plus Therapeutics, Inc. Upgrade